Effects of Transcranial Direct Current Stimulation (tDCS) on Patients With Chronic Orofacial Pain
Effects of Transcranial Direct Current Stimulation (tDCS) in Patients With Chronic Orofacial Pain Unresponsive to Conventional Treatment. A Randomized Controlled Trial.
Patients affected by chronic orofacial pain represent an emergent medical problem due to the lack of knowledge on the cause, pathophysiology and psychology of many of these conditions, that belongs to a multifactorial origin.
Particularly, temporomandibular joint disorders involve a series of symptoms that refers both to intrinsic and extrinsic joint conditions where pain can be associated to a reduction of the joint movement, click or to other sounds of the joint.
The lack of a recognized causal therapy led to the suggestion of many treatment modalities with a multidisciplinary approach for the management of symptoms that include the use of occlusal splints, physiotherapy-speech therapy, behavioral and physical therapy, drugs, chirurgical approaches. In most cases these strategies together allow the control of the symptoms, even though they aren't completely resolutive.
In these patients is frequent chronic pain and ineffectiveness of common drugs used.
It has been demonstrated how transcranial electrical brain stimulation with direct current (tDCS) is able to reduce the intensity and the duration of chronic pain.
Stimulating the motor cortex can reduce pain by modulating brain activities in the areas involved in cerebral circuits controlling pain, such as thalamus, facilitating the descendant inhibitory mechanisms and enhancing the number of opiates receptors.
This clinical trial is based on the evaluation of the effects of tDCS on pain and on activities daily living (ADL) participation patients with chronic orofacial pain that don't respond to other treatments.
研究概览
详细说明
Inclusion criteria:
- Male and female between 18 and 75 years old
- Clinic history of previous orofacial and/or dental surgery
- Chronic orofacial pain for more than a year measurable by the VAS more than 3 .
- Pain not responsive to pharmacological treatment (analgesic, anti inflammatory, opiaces, antidepressant drugs and physiotherapy modalities)
Outcome measures:
Subjects will be assessed before the beginning of the treatment (T0), after tDCS (T1) and after one month of stimulation(T2) .
In the two weeks prior to T0 the patient will be asked in a questionnaire to report daily the level of pain, anxiety and state of mind using the VAS. This period of observation is necessary for the patient to get used to these measures and to underline possible intra-subject changing.
• Clinic scales
-Visual Analogue Scale (VAS): it is one of the most used between scales for pain evaluation [18]
RDC/TMD AXIS I: diagnostic classification for temporomandibolar disfunction. RDC/TMD AXIS II: behavioral questionnaire (7 questions about chronic pain severity) which evaluates chronic pain following the graded scale for chronic pain.
- Symptoms Checklist-90-R scales (SCL 90-R): Depression and anxiety assessment for non-specific physical symptoms
- electrical pain threshold: The Digitimer High Voltage Stimulator model DS74 provides high voltage pulses of constant current up to 100mA, pulses are of short duration and the output current is variable ranging between 0 and 100mA. The Digitimer is used to evaluate the pain perception threshold by applying electrical stimulation to the index finger to a pulse duration of 200 ls. The initial current applied is 0mA and increases of 0.1 mA until the subject feels pain.
- Oral Health Impact Profile 49 (OHIP 49): provides a measure of social impact of oral disorders by providing a comprehensive measure of dysfunction, discomfort and disability resulting from the oral cavity conditions. The OHIP-49 is based on the adaptation of the World Health Organization classification.
- Pain detect Questionnaire
Pressor pain threshold
研究类型
注册 (实际的)
阶段
- 阶段2
联系人和位置
学习地点
-
-
-
Ferrara、意大利、44124
- Ferrara University Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Male and female between 18 and 75 years old
- Clinic history of previous orofacial and/or dental surgery
- Chronic orofacial pain for more than a year measurable by the VAS more than 3 .
- Pain not responsive to pharmacological treatment (analgesic, anti inflammatory, opiates, antidepressant drugs and physiotherapy modalities)
Exclusion Criteria:
- Contraindication to tDCS: presence of metallic implants that can be stimulated, moved or overheated by electric current, positive anamnesis for epilepsy, implantable systems ( ventriculoperitoneal shunt, pacemaker, intracranial pumps, intracranial metallic systems)
- Major neurological or psychiatric pathologies
- Pregnancy
- Severe hepatorenal and cardiopulmonary diseases
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器：sham tDCS
This group will receive sham-tDCS for 5 days.
The anode will be placed on the primary motor cortex (M1) of the dominant hemisphere and the cathode on the contralateral supraorbital area.
The direct current is transmitted through a pair of sponge electrodes, with a surface of 35 cm2 (7x5), soaked in saline solution and, it is generated by a constant current stimulator, with rechargeable batteries.
This continuous stimulation lasted 30 seconds, with an intensity of 1 milliampere.
|
2 milliampere sham direct current stimulation for 20 minutes daily for 5 days.
|
|
实验性的：real tDCS
This group will receive continuous stimulation lasting 20 minutes daily, for 5 days. Transcranial direct current stimulation (tDCS) will be administered as follows. The anode will be placed on the primary motor cortex (M1) of the dominant hemisphere and the cathode on the contralateral supraorbital area. The direct current is transmitted through a pair of sponge electrodes, with a surface of 35 cm2 (7x5), soaked in saline solution and, it is generated by a constant current stimulator, with rechargeable batteries. This continuous stimulation lasted 20 minutes, with an intensity of 1 milliampere. |
2 milliampere real direct current stimulation for 20 minutes daily for 5 days.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline in Visual Analogue Scale (VAS) for pain
大体时间：1) one day pre-tDCS 5 days treatment. 2) Every day, for 5 days pre and post tDCS stimulation. 3) one day post tDCS 5 days treatment. 4)Follow up at one month.
|
Visual analogue scale measure for pain.
Score range from 0-10.
For rating overall pain: mild = 1-3, moderate = 4-7, severe = 8-10 For rating Chronic Pain, excellent internal consistency for a single pair of rating between Numeric Pain Rating Scale and Visual Analogue Scale (r = 0.86)
|
1) one day pre-tDCS 5 days treatment. 2) Every day, for 5 days pre and post tDCS stimulation. 3) one day post tDCS 5 days treatment. 4)Follow up at one month.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Research Diagnostic Criteria Temporomandibular disorders (RDC/TMD) AXIS I
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
Diagnostic classification for temporomandibular disfunction.
|
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
|
Research Diagnostic Criteria Temporomandibular disorders RDC/TMD AXIS II
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
Behavioral questionnaire (7 questions about chronic pain severity) which evaluates chronic pain following the graded scale for chronic pain.
|
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
|
Symptoms Checklist 90-R scales (SCL 90-R)
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
Depression and anxiety assessment for non-specific physical symptoms.
|
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
|
Electrical and pressure pain threshold
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
The device for assessing pain is a high voltage stimulator provides high voltage pulses of constant current up to 100 milliampere, pulses are of short duration and the output current is variable ranging between 0 and 100 milliampere.
This device is used to evaluate the pain perception threshold by applying electrical stimulation to the index finger to a pulse duration of 200 ls.
The initial current applied is 0 milliampere and increases of 0.1 milliampere until the subject feels pain.
|
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
|
Oral Health Impact Profile 49 (OHIP 49)
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
Provides a measure of social impact of oral disorders by providing a comprehensive measure of dysfunction, discomfort and disability resulting from the oral cavity conditions.
The OHIP-49 is based on the adaptation of the World Health Organization classification.
|
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
|
Pain detect Questionnaire (PD-Q)
大体时间：1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
The PD-Q is a reliable screening tool with high sensitivity, specificity and positive predictive accuracy. Simple, patient-based, easy-to-use screening questionnaires can determine the prevalence of neuropathic pain components both in individual low back pain patients and in heterogeneous cohorts of such patients. Since NeP correlates with more intense pain, more severe co-morbidity and poorer quality of life, accurate diagnosis is a milestone in choosing appropriate therapy. |
1) one day pre 5 days tDCS treatment. 2) one day post 5 days tDCS treatment 3) One month follow up
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
sham tDCS的临床试验
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; University of Magdeburg; University of Waterloo招聘中
-
I.R.C.C.S. Fondazione Santa LuciaCampus Bio-Medico University完全的
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke (NINDS); University... 和其他合作者完全的
-
University of New MexicoUniversity of Miami; The City College of New York; The Mind Research Network; New Jersey Institute... 和其他合作者完全的